Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: Russia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20132
20152
20161
20175
20181
20193
20201
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting3
Recruiting3
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Federal Research Institute of Pediatric Hematology, Oncology and Immunology3
Celgene2
Ascentage Pharma Group Inc.1
Astellas Pharma Inc1
Astex Pharmaceuticals, Inc.1
Boehringer Ingelheim1
Daiichi Sankyo1
Eisai Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute20
Leukemia4
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Down Syndrome1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myelomonocytic, Chronic1
Lymphoma, Non-Hodgkin1
Multiple Myeloma1
Myelodysplastic Syndromes1
Neoplasms1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.